Related Experiment Video

Updated: Jun 14, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

KRAS and BRAF mutations in prostate carcinomas of Chinese patients

Yanying Shen1, Yachao Lu, Xiaolu Yin

  • 1Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.

Cancer Genetics and Cytogenetics
|March 23, 2010
PubMed

Insights

RAS/RAF/MEK/MAPK pathway mutations, specifically KRAS, are implicated in prostate cancer. This study found KRAS mutations in 9.1% of Chinese prostate carcinoma patients, but no BRAF mutations, suggesting KRAS

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RAS/RAF/MEK/MAPK pathway is crucial in various cancers, including prostate carcinoma.
  • Mutations in KRAS and BRAF can lead to pathway overactivation, but their prevalence varies geographically.
  • Previous studies have not reported on KRAS and BRAF mutation status in Chinese prostate carcinoma patients.

Purpose of the Study:

  • To investigate the frequency of KRAS and BRAF mutations in Chinese prostate carcinoma patients.
  • To analyze the association between identified mutations and clinicopathological features.
  • To determine the role of KRAS and BRAF mutations in the pathogenesis of prostate cancer in this population.

Main Methods:

  • Analysis of 121 prostate carcinoma samples from Chinese subjects.
  • Utilized mutant-enriched polymerase chain reaction-coupled sequencing.
  • Targeted sequencing of KRAS codons 12 and 13, and BRAF codon 600.

Main Results:

  • KRAS mutations were identified in 9.1% (11/121) of the prostate carcinoma samples.
  • No BRAF mutations were detected in any of the studied cases.
  • No significant association was found between KRAS mutations and tumor differentiation or clinical stage.

Conclusions:

  • KRAS mutations, but not BRAF mutations, appear to be involved in the development of prostate carcinoma in the Chinese population.
  • These findings contribute to understanding the molecular landscape of prostate cancer in specific ethnic groups.
  • Further research may explore therapeutic strategies targeting the RAS/RAF/MEK/MAPK pathway in Chinese prostate cancer patients.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...